Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet’s disease susceptibility
暂无分享,去创建一个
Akira Meguro | Massimo Gadina | Nobuhisa Mizuki | Elaine F. Remmers | Daniel L. Kastner | Inês Sousa | Tatsukata Kawagoe | I. Sousa | E. Remmers | D. Kastner | S. Oliveira | F. Shahram | S. Ohno | A. Meguro | N. Mizuki | M. Gadina | Y. Kirino | D. Ustek | Y. Ishigatsubo | Y. Ozyazgan | İ. Tuğal-Tutkun | F. Davatchi | A. Nadji | A. Ueda | A. Gül | B. Erer | M. Blake | Yohei Kirino | Yoshiaki Ishigatsubo | Ilknur Tugal-Tutkun | Emire Seyahi | Yilmaz Ozyazgan | Burak Erer | Duran Ustek | Colleen Satorius | Atsuhisa Ueda | Michael J. Ombrello | Ahmet Gül | Shigeaki Ohno | Masaki Takeuchi | Julie Le | Mary Blake | Fereydoun Davatchi | Vânia Francisco | Farhad Shahram | Bahar Sadeghi Abdollahi | Abdolhadi Nadji | Niloofar Mojarad Shafiee | Fahmida Ghaderibarmi | Sofia A. Oliveira | E. Seyahi | B. Abdollahi | T. Kawagoe | C. Satorius | V. Francisco | M. Takeuchi | Fahmida Ghaderibarmi | J. Le | Colleen L. Satorius
[1] M. Jeannet,et al. Letter: HL-A antigens in asymptomatic chronic HBAg carriers. , 1974, Lancet.
[2] Y. Okada,et al. Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy , 2015, Nature Genetics.
[3] Christopher I. Amos,et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R/IL12RB2 regions associated with Behçet's disease , 2010, Nature Genetics.
[4] A. Mirza,et al. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study , 2011, Annals of the rheumatic diseases.
[5] M. Netea,et al. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. , 2006, The Journal of infectious diseases.
[6] F. Alkuraya,et al. Study of Mendelian forms of Crohn's disease in Saudi Arabia reveals novel risk loci and alleles , 2014, Gut.
[7] A. Silman,et al. EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.
[8] P. D. de Bakker,et al. Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity , 2014, Proceedings of the National Academy of Sciences.
[9] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[10] Nobuaki Yoshida,et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.
[11] O. Delaneau,et al. A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.
[12] A. Uitterlinden,et al. Genome-Wide Association Study in an Admixed Case Series Reveals IL12A as a New Candidate in Behçet Disease , 2015, PloS one.
[13] K. Shianna,et al. Long-range LD can confound genome scans in admixed populations. , 2008, American journal of human genetics.
[14] A. Kijlstra,et al. TNFAIP3 gene polymorphisms confer risk for Behcet’s disease in a Chinese Han population , 2012, Human Genetics.
[15] M. Netea,et al. Endogenous Interleukin (IL)–1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis , 2006 .
[16] S. Ohno,et al. HLA-B*51 and Behçet Disease , 2012, Ocular immunology and inflammation.
[17] H. Inoko,et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci , 2010, Nature Genetics.
[18] L. Punzi,et al. Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy , 2014, Mediators of inflammation.
[19] F. Al-Mohanna,et al. Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis , 2015, Arthritis & rheumatology.
[20] R. Cortese,et al. Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.
[21] Javier Martín,et al. Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci , 2016, PloS one.
[22] A. Kijlstra,et al. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. , 2013, Investigative ophthalmology & visual science.
[23] C. Cordon-Cardo,et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. , 1989, The New England journal of medicine.
[24] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[25] I. Sousa,et al. FUT2: filling the gap between genes and environment in Behçet's disease? , 2015, Annals of the rheumatic diseases.
[26] Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. , 1990, Lancet.
[27] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[28] Buhm Han,et al. Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.
[29] Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease , 2015, Journal of Inflammation.
[30] Philip Rosenstiel,et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype , 2011, Proceedings of the National Academy of Sciences.
[31] H. Inoko,et al. Immunology and functional genomics of Behçet's disease , 2003, Cellular and Molecular Life Sciences CMLS.
[32] Alexander F. Wilson,et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease , 2013, Proceedings of the National Academy of Sciences.
[33] P. Donnelly,et al. A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.
[34] G. Hatemi,et al. Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease. , 2008, Clinical and experimental rheumatology.
[35] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[36] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[37] S. Ohno,et al. HL-A5 AND BEHCET'S DISEASE , 1973 .
[38] P. Schirmacher,et al. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis , 2014, Alimentary pharmacology & therapeutics.
[39] M. Brown,et al. Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.
[40] A. Bradley,et al. C13orf31 (FAMIN) is a central regulator of immunometabolic function , 2016, Nature Immunology.
[41] G T Ferguson,et al. Recommendations for the management of COPD. , 2000, Chest.
[42] M. Netea,et al. Genomewide association study of leprosy. , 2010, The New England journal of medicine.
[43] A. Pacheco,et al. NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians , 2014, Human Genetics.
[44] Emily K. Tsang,et al. The landscape of genomic imprinting across diverse adult human tissues , 2015, Genome research.
[45] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[46] Simon C. Potter,et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins , 2012, Nature Genetics.
[47] D. Hu,et al. Associations of FUT2 and FUT3 gene polymorphisms with Crohn's disease in Chinese patients , 2014, Journal of gastroenterology and hepatology.
[48] O. Ozcebe,et al. Behçet's disease. , 2019, The New England journal of medicine.
[49] Tsun-Po Yang,et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..
[50] J. Bertranpetit,et al. A natural history of FUT2 polymorphism in humans. , 2009, Molecular biology and evolution.
[51] G. Abecasis,et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.
[52] N. Bovin,et al. Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. , 2005, The Journal of infectious diseases.
[53] Pak Chung Sham,et al. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..
[54] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[55] C. Wijmenga,et al. Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease , 2013, Nature Genetics.
[56] P. Elias,et al. Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. , 2004, The Journal of investigative dermatology.
[57] S. Ohno,et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. , 1999, Tissue antigens.
[58] J. Nikkilä,et al. Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine , 2011, PloS one.
[59] Akira Meguro,et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.
[60] Y. Mizushima. Recent research into Behçet's disease in Japan. , 1988, International journal of tissue reactions.
[61] L. Guillevin,et al. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. , 2009, Arthritis and rheumatism.